PT Treatment For Copd
PT Treatment For Copd
PT Treatment For Copd
COPD
GOALS
• Treatment of underlying problem
• Clearance of tracheobronchial secretions
• Relieve symptoms
• Antibiotics for infection
• Reversal of airflow obstruction
• Improve quality of life
• Prevent disease progression
PHARMACOTHERAPY
• Smoking Cessation has shown a significant improvement in the rate of
decline in pulmonary function
• Bronchodilators: the primary treatment for almost all patients with COPD
used for symptomatic benefit and to reduce exacerbations
Used in the form of inhaler
• Anticholinergic Muscarinic Antagonists:
Short-acting ipratropium bromide improves symptoms with acute
improvement in FEV1 .
Long-acting muscarinic antagonists (LAMA, including aclidinium,
glycopyrrolate, tiotropium, and umeclidinium) improve symptoms and reduce
exacerbations
• Beta Agonists:
Short-acting beta agonists ease symptoms with acute improvements in
lung function.
Long-acting agents (LABA) arformoterol, formoterol, indacaterol,
olodaterol, salmeterol, and vilanterol provide symptomatic benefit and
reduce exacerbations
• Oxygen Supplemental: O2 is the only pharmacologic therapy to
decrease mortality rates in patients with COPD.
For patients with resting hypoxemia (resting O2 saturation ≤88% in any
patient or ≤89% with signs of pulmonary hypertension or right heart
failure), the use of O2 has impact on mortality.
• Long-term maintenance therapy includes the use of nebulized
medication
SURGICAL MANAGEMENT
• The procedure involved is resection of areas of bronchiectatic lung.
Indications of surgery in bronchiectasis are the following:
Children or young adults with localised lesions, who do not respond to
medical treatment.
Recurrent haemoptysis.
Recurrent localised pneumonias.
• Reduce breathlessness